| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Eton Pharmaceuticals, Inc. | Chief Financial Officer | Common Stock | 213,420 | $3,301,607 | $15.47 | 14 Jan 2026 | Direct |
| Eton Pharmaceuticals, Inc. | Chief Financial Officer | Restricted Stock Units | 279,931 | $206,527 | $7.98 | 12 Jan 2026 | Direct |
| Eton Pharmaceuticals, Inc. | Chief Financial Officer | Employee Stock Option (Right to Buy) | 254,075 | 12 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ETON | Eton Pharmaceuticals, Inc. | 12 Jan 2026 | 3 | -$35,473 | 4 | Chief Financial Officer | 14 Jan 2026, 18:02 |
| ETON | Eton Pharmaceuticals, Inc. | 11 Dec 2025 | 2 | -$77,169 | 4 | Chief Financial Officer | 12 Dec 2025, 16:55 |
| ETON | Eton Pharmaceuticals, Inc. | 19 Aug 2025 | 2 | -$673,714 | 4 | Chief Financial Officer | 20 Aug 2025, 17:14 |
| ETON | Eton Pharmaceuticals, Inc. | 03 Jan 2025 | 2 | $0 | 4 | Chief Financial Officer | 06 Jan 2025, 16:15 |
| ETON | Eton Pharmaceuticals, Inc. | 13 Feb 2024 | 1 | $0 | 4 | Chief Financial Officer | 15 Feb 2024, 16:21 |
| ETON | Eton Pharmaceuticals, Inc. | 03 Mar 2023 | 1 | $0 | 4 | Chief Financial Officer | 03 Mar 2023, 15:10 |
| ETON | Eton Pharmaceuticals, Inc. | 12 Jul 2022 | 1 | $0 | 4 | Chief Financial Officer | 18 Jul 2022, 16:32 |
| ETON | Eton Pharmaceuticals, Inc. | 11 Apr 2022 | 0 | $0 | 3 | Chief Financial Officer | 14 Apr 2022, 16:05 |